Carnegie Investment Counsel Sells 1,830 Shares of SPDR S&P Biotech ETF $XBI

Carnegie Investment Counsel lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 49,615 shares of the exchange traded fund’s stock after selling 1,830 shares during the period. Carnegie Investment Counsel’s holdings in SPDR S&P Biotech ETF were worth $4,115,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in XBI. DHJJ Financial Advisors Ltd. purchased a new position in SPDR S&P Biotech ETF during the second quarter valued at $25,000. Garrison Bradford & Associates Inc. purchased a new position in SPDR S&P Biotech ETF during the first quarter valued at $39,000. Compass Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 46.0% during the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after buying an additional 200 shares during the period. Golden State Wealth Management LLC lifted its position in SPDR S&P Biotech ETF by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 319 shares during the period. Finally, Avalon Trust Co purchased a new position in SPDR S&P Biotech ETF during the first quarter valued at $57,000.

SPDR S&P Biotech ETF Trading Up 0.8%

Shares of SPDR S&P Biotech ETF stock opened at $108.39 on Friday. The firm has a market capitalization of $6.65 billion, a P/E ratio of 11.47 and a beta of 0.97. The business has a fifty day simple moving average of $98.08 and a two-hundred day simple moving average of $87.75. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $110.96.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.